The DGfZ 2014 took place at the Center for Regenerative Therapies Dresden (CRTD ) in Dresden from October 15th – 17th 2014 and we were happy to welcome you again.
We had more than 20 exhibitors and 200 participants as the result of the DGfZ 2014 meeting at the Center for Regenerative Therapies Dresden (CRTD ) .” Cytometry Across Disciplines “ was the topic, which has attracted considerable interest. The positive response from exhibitors , guest speakers and participants from over 10 countries, is a confirmation for the organizers , Prof. Dr. Leoni Kunz- Schughart (National Centre for Radiation Research in Oncology – OncoRay , Chairman of the Company) and Dr. Denis Corbeil ( biotechnology Center Dresden – Biotec) that the intensive preparation of the Congress has been worthwhile. Prof. Dr. Kunz- Schughart : ” The interdisciplinary scientific program with numerous high-profile international experts and pleasing environment were key to the success of the event”.
Already the 2013 conference succeeded in building a bridge between multiple cytometric and cell analytical methodologies. It was an excellent opportunity to discuss new technological developments in the context of the many challlenges in biomedical research, that have to be addressed. A special highlight was the presentation by Prof. Dr. David Harris , Arizona , United States , founder of the world’s first cord blood bank on the topic ” The Future of Cord Blood Stem Cell Banking: Regenerative Medicine & Cellular Therapies ” .
Without the proactive participation of all working group members and the support of sponsors and funding agencies in the event of this high quality would not have been possible. For this we are particularly grateful to the organizers . ” At this point in particular, the German Research Foundation ( DFG) and the International Society for Advancement of Cytometry ( ISAC ) should be mentioned.
The Organizers
Leoni A. Kunz-Schughart, PhD (President of the DGfZ e.V.)
Prof. of Tumor Pathophysiology
OncoRay – National Center for Radiation Research in Oncology
&
Denis Corbeil, PhD
Biotechnology Center (Biotec), TU Dresden